341 related articles for article (PubMed ID: 24631185)
1. Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
Ozadali K; Tan OU; Yogeeswari P; Dharmarajan S; Balkan A
Bioorg Med Chem Lett; 2014 Apr; 24(7):1695-7. PubMed ID: 24631185
[TBL] [Abstract][Full Text] [Related]
2. 2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in vitro antimycobacterial studies.
Makam P; Kankanala R; Prakash A; Kannan T
Eur J Med Chem; 2013 Nov; 69():564-76. PubMed ID: 24095750
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
Turan-Zitouni G; Ozdemir A; Kaplancikli ZA; Benkli K; Chevallet P; Akalin G
Eur J Med Chem; 2008 May; 43(5):981-5. PubMed ID: 17719146
[TBL] [Abstract][Full Text] [Related]
4. Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis.
Jeankumar VU; Chandran M; Samala G; Alvala M; Koushik PV; Yogeeswari P; Salina EG; Sriram D
Bioorg Med Chem Lett; 2012 Dec; 22(24):7414-7. PubMed ID: 23137434
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antimycobacterial activity and docking study of 2-aroyl-[1]benzopyrano[4,3-c]pyrazol-4(1H)-one derivatives and related hydrazide-hydrazones.
Angelova VT; Valcheva V; Pencheva T; Voynikov Y; Vassilev N; Mihaylova R; Momekov G; Shivachev B
Bioorg Med Chem Lett; 2017 Jul; 27(13):2996-3002. PubMed ID: 28512022
[TBL] [Abstract][Full Text] [Related]
6. A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of new-fangled dispiropyrrolothiazoles as antimycobacterial agents.
Almansour AI; Ali S; Ali MA; Ismail R; Choon TS; Sellappan V; Elumalai KK; Pandian S
Bioorg Med Chem Lett; 2012 Dec; 22(24):7418-21. PubMed ID: 23122863
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents.
More UA; Joshi SD; Aminabhavi TM; Gadad AK; Nadagouda MN; Kulkarni VH
Eur J Med Chem; 2014 Jan; 71():199-218. PubMed ID: 24292339
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.
Roy KK; Singh S; Sharma SK; Srivastava R; Chaturvedi V; Saxena AK
Bioorg Med Chem Lett; 2011 Sep; 21(18):5589-93. PubMed ID: 21783364
[TBL] [Abstract][Full Text] [Related]
10. Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2H-chromene and coumarin scaffold.
Angelova VT; Valcheva V; Vassilev NG; Buyukliev R; Momekov G; Dimitrov I; Saso L; Djukic M; Shivachev B
Bioorg Med Chem Lett; 2017 Jan; 27(2):223-227. PubMed ID: 27914798
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues.
Nagesh HN; Suresh A; Sairam SD; Sriram D; Yogeeswari P; Chandra Sekhar KV
Eur J Med Chem; 2014 Sep; 84():605-13. PubMed ID: 25062011
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N,N-disubstituted dithiocarbamate/O-alkyldithiocarbonate derivatives.
Güzel O; Salman A
Bioorg Med Chem; 2006 Dec; 14(23):7804-15. PubMed ID: 16931027
[TBL] [Abstract][Full Text] [Related]
13. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones.
Ponnuchamy S; Kanchithalaivan S; Ranjith Kumar R; Ali MA; Choon TS
Bioorg Med Chem Lett; 2014 Feb; 24(4):1089-93. PubMed ID: 24472146
[TBL] [Abstract][Full Text] [Related]
15. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
[TBL] [Abstract][Full Text] [Related]
16. Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
Mhiri C; Boudriga S; Askri M; Knorr M; Sriram D; Yogeeswari P; Nana F; Golz C; Strohmann C
Bioorg Med Chem Lett; 2015 Oct; 25(19):4308-13. PubMed ID: 26271585
[TBL] [Abstract][Full Text] [Related]
17. 2-aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds - conventional heating in comparison with MW-assisted synthesis.
Zampieri D; Mamolo MG; Laurini E; Scialino G; Banfi E; Vio L
Arch Pharm (Weinheim); 2009 Dec; 342(12):716-22. PubMed ID: 19921681
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimicrobial activity of some novel hydrazide, benzochromenone, dihydropyridine, pyrrole, thiazole and thiophene derivatives.
Refat HM; Fadda AA
Eur J Med Chem; 2013; 70():419-26. PubMed ID: 24184775
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2-c]pyridine Mannich bases.
Jose G; Suresha Kumara TH; Sowmya HBV; Sriram D; Guru Row TN; Hosamani AA; More SS; Janardhan B; Harish BG; Telkar S; Ravikumar YS
Eur J Med Chem; 2017 May; 131():275-288. PubMed ID: 28340368
[TBL] [Abstract][Full Text] [Related]
20. New bithiazolyl hydrazones: Novel synthesis, characterization and antitubercular evaluation.
Bhalerao MB; Dhumal ST; Deshmukh AR; Nawale LU; Khedkar V; Sarkar D; Mane RA
Bioorg Med Chem Lett; 2017 Jan; 27(2):288-294. PubMed ID: 27914801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
